£325.00

It has never been this cheap. We have no record of a lower price.

£325 today · cheaper than every other day in the last 3 months

Anti-Migraine Drug Outlook in Middle East (2011-2016)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 91 days · 91 data points

Historical
Generating forecast…
£325.00 £308.75 £315.25 £321.75 £328.25 £334.75 £341.25 11 August 2026 02 September 2026 25 September 2026 17 October 2026 09 November 2026
View at Amazon ↗

Price data updated today

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 91 days • 1 price levels

Days at Price
91 days 0 23 46 68 91 £325 Days at Price

Price Analysis

Most common price: £325 (91 days, 100.0%)

Price range: £325 - £325

Price levels: 1 different prices over 91 days

Description

This econometric study provides a detailed analysis of the anti-migraine drug market in the Middle East from 2011 to 2016. Using sophisticated econometric models to project fundamental economic dynamics, the report offers essential data for understanding market trends across individual countries and the broader region. Readers gain access to estimates for latent demand, also known as potential industry earnings (P.I.E.), presented in millions of U.S. dollars for each reported year. The study includes comparative benchmarks such as the percent share each country holds within the region and the global market. These metrics allow for quick assessment of specific countries in relation to their peers, making this a valuable resource for economic analysis and industry forecasting.

Key Features

Provides annual estimates for latent demand and potential industry earnings (P.I.E.) in millions of U.S. dollars.

Includes comparative benchmarks showing the percent share of each country relative to the region and the globe.

Utilizes econometric models to project fundamental economic dynamics within and across Middle Eastern countries.

Covers the specific market outlook for anti-migraine drugs during the 2011-2016 period.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
15 January 2011
Listed Since
09 June 2011

Similar Products You Might Like

Anti-Migraine Drug Outlook: Africa & Middle East Study
99% match

Anti-Migraine Drug Outlook: Africa & Middle East Study

£425.00 05 Nov 2026
Anti-Migraine Drug Outlook in Asia 2016-2021 Study
99% match

Anti-Migraine Drug Outlook in Asia 2016-2021 Study

£425.00 06 Nov 2026
Anti-Migraine Drug Outlook Latin America 2016-2021 Study
99% match

Anti-Migraine Drug Outlook Latin America 2016-2021 Study

£425.00 07 Nov 2026
The 2013-2018 Outlook for Anti-Migraine Drugs in Europe & the Middle East
99% match

The 2013-2018 Outlook for Anti-Migraine Drugs in Europe & the Middle East

£325.00 05 Nov 2026
Anti-Migraine Drug Outlook North America & Caribbean Study
99% match

Anti-Migraine Drug Outlook North America & Caribbean Study

£425.00 05 Nov 2026
Anti-Migraine Drugs in Europe Outlook 2016-2021 Report
99% match

Anti-Migraine Drugs in Europe Outlook 2016-2021 Report

£425.00 09 Nov 2026
Anti-Migraine Drug Outlook in Oceana 2016-2021 Study
99% match

Anti-Migraine Drug Outlook in Oceana 2016-2021 Study

£425.00 26 Sep 2026
The 2023-2028 Outlook for Anti-Migraine Drugs in China
99% match

The 2023-2028 Outlook for Anti-Migraine Drugs in China

£495.00 04 Nov 2026
The 2013-2018 Outlook for Anti-Migraine Drugs in Africa
99% match

The 2013-2018 Outlook for Anti-Migraine Drugs in Africa

£325.00 31 Oct 2026
The 2023-2028 Outlook for Anti-Migraine Drugs in Japan
99% match

The 2023-2028 Outlook for Anti-Migraine Drugs in Japan

£495.00 29 Oct 2026
US Anti-Migraine Drug Market Outlook 2016-2021 Study
99% match

US Anti-Migraine Drug Market Outlook 2016-2021 Study

£595.00 06 Nov 2026
Anti-Migraine Drug Outlook in Greater China 2016-2021
98% match

Anti-Migraine Drug Outlook in Greater China 2016-2021

£595.00 25 Aug 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in India
98% match

The 2016-2021 Outlook for Anti-Migraine Drugs in India

£595.00 03 Nov 2026
The 2021-2026 World Outlook for Anti-Migraine Drugs
98% match

The 2021-2026 World Outlook for Anti-Migraine Drugs

£795.00 09 Nov 2026
US Anti-Migraine Drug Market Outlook 2023-2028 Study
98% match

US Anti-Migraine Drug Market Outlook 2023-2028 Study

£520.00 07 Nov 2026
Anti-Migraine Drugs in India Outlook 2023-2028 Study
98% match

Anti-Migraine Drugs in India Outlook 2023-2028 Study

£515.00 09 Nov 2026
The 2016 Report on Anti-Migraine Drugs: World Market Segmentation by City
98% match

The 2016 Report on Anti-Migraine Drugs: World Market Segmentation by City

£995.00 28 Oct 2026
US Anti-Migraine Drug Outlook 2023-2028 - Zip Code Study
98% match

US Anti-Migraine Drug Outlook 2023-2028 - Zip Code Study

£490.00 04 Sep 2026
2025-2030 World Outlook for Anti-Migraine Drugs Study
98% match

2025-2030 World Outlook for Anti-Migraine Drugs Study

Price unavailable
The 2023-2028 World Outlook for Acute-Treatment Migraine Drugs
98% match

The 2023-2028 World Outlook for Acute-Treatment Migraine Drugs

£795.00 07 Nov 2026
Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)
97% match

Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)

OmniScriptum

£70.00 30 Sep 2026
Migraine and Headache Disorders: Global Perspective - SDG3
97% match

Migraine and Headache Disorders: Global Perspective - SDG3

Springer

£95.74 25 Sep 2026
Interventional Management of Migraines and Headache Disorders Book
97% match

Interventional Management of Migraines and Headache Disorders Book

Elsevier

£119.49 02 Oct 2026
Management of Migraine Pain: Emerging Opportunities and Challenges
97% match

Management of Migraine Pain: Emerging Opportunities and Challenges

Springer

£162.90 02 Oct 2026